Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii

This publication has 15 references indexed in Scilit:

• The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
  Vaccine, 1995
• Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
  The Journal of Experimental Medicine, 1995
• Comparison in the immunological properties ofBorrelia burgdorferiisolates fromIxodes ricinusderived from three endemic areas in Switzerland
  Epidemiology and Infection, 1994
• Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites
  Immunology Letters, 1994
• Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype
  Vaccine, 1993
• Delineation of Borrelia burgdorferi Sensu Stricto, Borrelia garinii sp. nov., and Group VS461 Associated with Lyme Borreliosis
  International Journal of Systematic and Evolutionary Microbiology, 1992
• Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi
  Medical Microbiology and Immunology, 1992
• Recombinant Outer Surface Protein A from Borrelia burgdorferi Induces Antibodies Protective against Spirochetal Infection in Mice
  The Journal of Infectious Diseases, 1991
• Linear Plasmids of the Bacterium Borrelia burgdorferi Have Covalently Closed Ends
  Science, 1987
• Lyme Disease—a Tick-Borne Spirochetosis?
  Science, 1982